BridgeMD
New treatment option for Rotator Cuff Tears
Official title Microfracture at Proximal Humerus Lateral to Footprint Could Enhance the Rotator Cuff Healing
ClinicalTrials.gov ID: NCT05624164
What this study is testing
- What it's testing
- The goal of this clinical trial is to test whether there is any effect on rotator cuff healing by making microfracture at the lateral side of the footprint. The main question it aims to answer are: [whether the lateralized microfracture could decrease the retear rate after arthroscopy rotator cuff repair.] [whether the lateralized microfracture could improve the functional recovery after arthroscopy rotator cuff repair.] Participants with medium to larger size rotator cuff tears will be randomly assigned to the study group treated with lateralized microfracture immediately after arthroscopy rotator cuff repair or the control group treated with conventional arthroscopy rotator cuff repair without microfracture.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Medium to large Rotator cuff tear(1cm-5cm) diagnosed by MRI
- Patients can complete the follow-up and comply with all post-operative rehab instructions
- Failure of non-operative treatment for at least 3 months
You likely can't join if
- Revision rotator cuff surgery
- Partial thickness rotator cuff tears
- Small (less than 1cm) and Massive (greater than 5cm) rotator cuff tears
- Disease history of the affected shoulder
- Systemic immune diseases
- Irreparable rotator cuff tear
The study team makes the final eligibility decision.
Where it's taking place
- Nantong, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nantong, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.